OVERVIEW

The Importance of Treating What Matters to the Patient - Impact of Psoriatic Arthritis Therapies on Patient-Reported Outcomes is organized by CME Outfitters, LLC and held from Nov 07, 2018 - Nov 07, 2019.?

Target Audience
Rheumatologists, dermatologists, physicians, physician assistants, nurse practitioners, nurses, and pharmacists who treat patients with psoriatic arthritis.

Credit Information
CME Credit (Physicians):
USF Health designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Statement of Need
When treating psoriatic arthritis (PsA), clinicians usually speak of three main domains of efficacy: improvement in signs and symptoms, inhibition of structural progression, and improvement in patient-reported outcomes. Utilizing patient-reported outcomes is important when assessing patients and the therapies that they are receiving. It is imperative that clinicians understand what patients expect out of their PsA treatment and how it impacts both their pain levels and quality of life.

In this CME Outfitters CME Snack, expert faculty focus on treat-to-target approaches and digital health tools. Treat-to-target approaches are important for proper treatment as without having targets as ways of measuring how a patient is doing, clinicians have no way of improving on care over time. Digital health tools help both the clinician and the patient by providing both treatment guidelines and the ability to monitor disease progression and medication adherence.

Learning Objectives
At the end of this CE activity, participants should be able to:
• Evaluate recent clinical trial data regarding the impact of long-term treatment on improving pain and quality of life.

Additional details will be posted as soon as they are available.